1. Introduction {#sec1}
===============

Longitudinally extensive transverse myelitis (LETM) is characterized by spinal cord inflammation extending vertically through three or more vertebral segments \[[@B1]\]. The widespread use of magnetic resonance imaging (MRI) has revealed small cell lung cancer (SCLC) to be associated with many primary pathologies, including inflammatory diseases (collagen disease, neuromyelitis optica, Sjögren\'s syndrome, systemic lupus erythematosus, neuro-Behçet\'s disease, and sarcoidosis); infectious diseases (human T-lymphotropic virus-1-associated myelopathy, human immunodeficiency virus infection, and adverse reaction to influenza vaccination); and noninflammatory diseases (intramedullary spinal neoplasms, spinal cord infarction, and spinal dural arteriovenous fistula) \[[@B1]--[@B14]\]. LETM has a heterogeneous pathogenesis, but reported cases associated with malignant disorders were very rare ([Table 1](#tab1){ref-type="table"}). Here, we report a case of LETM due to intramedullary metastasis of small-cell lung carcinoma (SCLC), with rapid progression of paraplegia and sensory disturbance of the lower limbs. This patient presented with LETM on whole-spine MRI; despite intensive treatment, he died 47 days after admission. An autopsy was performed to assess the pathological findings of LETM.

2. Case Presentation {#sec2}
====================

A 74-year-old man, a habitual smoker, developed gait disturbance with exacerbation in the following 8 days. At the time of admission, he had difficulty in walking without assistance. His past medical history was unremarkable. On admission, he was fully alert. Neurological examination revealed sensory deficits, predominantly of deep sensation, and sphincter dysfunction with constipation and urinary disturbance. Manual muscle tests of all limbs indicated no paralysis, but lower limbs exhibited mild spasticity. Patellar and Achilles tendon reflexes were bilaterally brisk. Vibratory sensation was bilaterally diminished below the anterior superior iliac spine, but temperature and pain modalities were preserved. All tested hematological and biochemical parameters were within normal, including thyroid function, serum immunoglobulin, and serum vitamin B12. The levels of anti-SSA and anti-SSB antibodies were below 7.0 U/mL. Progastrin-releasing peptide level was elevated to 189 pg/mL (normal \< 70 pg/mL), and carcinoembryonic antigen level was also considerably high (59.7 ng/mL, normal \< 5.0 ng/mL). MRI revealed extensive intramedullary abnormal intensity from the upper thoracic cord down to conus medullaris. An intramedullary spinal cord tumor was detected at T10-T11 that was enhanced by gadolinium ([Figure 1](#fig1){ref-type="fig"}). Chest computed tomography (CT) scans revealed a small nodular lesion of 18 × 21 mm with spicula in the right lung S1 and hilar lymph node swelling on the right side, verified as small-cell carcinoma from biopsy specimen. Abdominal CT scans with iopamidol did not detect metastasis to the liver, spleen, or kidney. The metastasis led to gait disturbance and other sensorimotor symptoms. Initially, the patient was treated with intravenous methylprednisolone at 1,000 mg/day for 3 days, followed by oral prednisolone at 50 mg/day, which are not effective. Then he underwent an emergent microsurgical tumor resection at 9 days after admission. The mass obtained from surgical resection contained atypical cells with chromatin condensation that were synaptophysin/CD56 positive but chromogranin A negative (Figures [2(a)](#fig2){ref-type="fig"}−[2(c)](#fig2){ref-type="fig"}). After the resection, lumbar MRI indicated improvement of LETM. Neurological functions continued to deteriorate, and the patient died of pulmonary hemorrhage 47 days after admission. Autopsy confirmed a 20 mm SCLC in the right upper lung with right hilar adenopathy. Spinal sections showed mild edematous changes associated with the infiltration of lymphocytes and plasma cells in the gray matter. However, there were no cancer cells in the spinal cord, even at the edges of sections from T10-L1. Histological examination of the whole brain revealed modest lymphocyte proliferation in the cortex and around the lateral ventricles but no sign of metastasis.

In contrast to LETM revealed by MRI and biopsy results indicating SCLC metastasis into the spine, postmortem pathology revealed only mild edematous changes localized around the dorsal horn. Furthermore, there were no signs of gray matter tumors or meningeal carcinomatosis and no pencil-shaped softening indicative of necrosis in autopsy spine samples.

3. Discussion {#sec3}
=============

In our patient, metastasis of lung carcinoma to the spinal cord resulted in intramedullary spinal cord tumors and LETM. These tumors are observed in only 1%-2% patients with cancer at autopsy and in only 8.5% cases with central nervous system metastasis, most commonly from lung carcinoma \[[@B15]\]. LETM is detected on MRI more frequently than ever before. However, the precise mechanism underlying LETM development remains unknown. To our knowledge, It is very rare that LETM is caused by metastasis.

The pathological findings in the spinal cord of our patient indicate mild changes of edema without malignant cell invasion or metastasis. These findings suggest that LETMs themselves are reversible by ameliorating edema or temporary inflammation. Ohnaka et al. described that LETM was the result of lung carcinoma that completely disappeared after tumor resection \[[@B3]\]. They concluded that edema was the main pathology associated with LETM. In fact, many previous reports prove that LETMs due to inflammatory diseases can be ameliorated by medications ([Table 1](#tab1){ref-type="table"}). Even intramedullary spinal cord metastases can be temporarily treated by tumor resection \[[@B3]\]. We speculate that gray matter is more sensitive to damage by venous congestion than white matter because of the difference in water distribution. This difference can lead to intramedullary LETMs. There were some discrepancies between clinical manifestations and spinal MRI findings in the case described here. These particular findings also confirm the slight differences in LETM.

Our patient developed paraplegia as the initial symptom. Intramedullary spinal cord metastases have a high frequency (20%--40%) of neurological deficits as the first symptom before a diagnosis of cancer \[[@B15]\]. Kalayci et al. reported an average 52 days from neurological symptom onset to cancer diagnosis. Because this gap may result in cancer exacerbation, LETM should be considered as a critical sign of metastasis or primary tumors.

LETM can be caused by diverse spectrum of etiology; however, most of the patients presented in association with autoimmune disorders. ([Table 1](#tab1){ref-type="table"}). We explored papers describing LETM appearing on MRI in PubMed in the past 3 years ([Table 1](#tab1){ref-type="table"}). Many reports described discrepancies between the findings of MRI and clinical symptoms. Their initial symptoms were limited weakness and numbness in lower limbs, despite the broad emergence of LETM \[[@B2]--[@B14]\]. Despite mild changes in LETM, the prognosis in cases with metastasis is generally poor, with a 3-4-month mortality rate of approximately 80% \[[@B15]\]. These results depend on the stage of malignancy. Metastasis itself is associated with poor prognosis.

4. Conclusions {#sec4}
==============

LETM may present as symptoms of intramedullary spinal cord metastasis. Cases complicated with primary malignant disorders are heralded by poor prognosis, but some may result in a significant symptom relief by surgical resection. We emphasize that precise and rapid diagnosis of LETM is needed to optimize treatment success.
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![Thoracic magnetic resonance imaging reveals an intramedullary long spinal cord lesion from T3 to lower levels at 1 day after admission. (a) Sagittal T2-weighted image. (b) Gadolinium enhancement of the lesion at T10-T11. (c) Axial T2-weighted image at T10, revealing a high-intensity signal in the center of the spinal cord.](CRIM.NM2013-305670.001){#fig1}

![(a--c) Histopathology of the surgically resected spinal cord tumor, revealing a high nuclear/cytoplasmic ratio with necrosis. The sections were stained by hematoxylin and eosin (H&E) (a) following immunostaining with synaptophysin (b) and CD56 antibodies (c). Both synaptophysin- and CD56-positive cells were observed. The tumor was attributed to small-cell lung carcinoma metastasis. Original magnification ×100.](CRIM.NM2013-305670.002){#fig2}

###### 

Clinical features of LETM reported previously within 3 years.

  Authors                        Year     Age     Gender                                The extent of spinal cord lesion on MRI findings      Initial symptoms                                  Pathogenesis                            Prognosis
  ------------------------------ -------- ------- ------------------------------------- ----------------------------------------------------- ------------------------------------------------- --------------------------------------- -------------------
  Graham et al. \[[@B14]\]       2013     25      Male                                  T3-L2                                                 Spastic paraparesis                               Neuro-Behçet\'s disease                 Improved
                                                                                                                                                                                                                                        
  Huang et al. \[[@B13]\]        2013     39      Male                                  C3-conus medullaris                                   Motor and sensory disturbance in lower limbs      SLE                                     Not improved
                                                                                                                                                                                                                                        
  Salazar et al. \[[@B12]\]      2013     46      Male                                  Entire spinal cord                                    Leg weakness, ataxia, and paresthesia             NMO/HIV                                 Improved
                                                                                                                                                                                                                                        
  Coulter et al. \[[@B11]\]      2012     18      Male                                  T3-conus medullaris                                   Spastic paraplegia and pyramidal weakness         Neuro-Behçet\'s disease                 Improved
                                                                                                                                                                                                                                        
  White et al. \[[@B10]\]        2012     18      Male                                  T3-conus medullaris                                   Numbness and flaccid paralysis in lower limbs     SLE                                     Improved
                                                                                                                                                                                                                                        
  Stanifer et al. \[[@B9]\]      2012     50      Female                                C4-T4                                                 Motor and sensory disturbance in all four limbs   Sjögren\'s syndrome                     Improved
                                                                                                                                                                                                                                        
  Franciotta et al. \[[@B8]\]    2011     62      Female                                C6-T11                                                Right leg weakness and numbness in lower limbs    NMO                                     Improved
                                                                                                                                                                                                                                        
  Habek et al. \[[@B7]\]         2011     43      Female                                Medulla oblongata to C7                               Spastic tetraparesis                              NMO spectrum disorder                   Improved
                                                                                                                                                                                                                                        
  Itami et al. \[[@B6]\]         2011     73      Female                                Entire spinal cord                                    Gait disturbance                                  HTLV-1-associated myelopathy            Improved
                                                                                                                                                                                                                                        
  Kumar et al. \[[@B5]\]         2011     82      Female                                T3-T11                                                Lower limbs weakness and numbness                 Intravascular lymphoma                  Died
                                                                                                                                                                                                                                        
  Nightingale et al. \[[@B4]\]   2011     78      Male                                  C5-T10                                                Bilateral leg weakness                            NMO                                     Not improved
  31                             Female   C5-T4   Bilateral leg weakness and numbness   NMO spectrum disorder                                 Improved                                                                                  
                                                                                                                                                                                                                                        
  Ohnaka et al. \[[@B3]\]        2010     34      Male                                  From T3 vertebral body to conus medullaris            Paraplegia in lower limbs                         Lung cancer                             Symptoms remained
                                                                                                                                                                                                                                        
  Akkad et al. \[[@B2]\]         2010     27      Female                                From the top of cervical vertebrae to thoracic cord   Weakness and paresthesias in lower limbs          Vaccination against influenza vaccine   Improved
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